Cargando…
Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line
Trichosanthin (TCS) is a traditional Chinese herbal medicine used to treat some gynecological diseases. Its effective component has diverse biological functions, including antineoplastic activity. The human trophoblast cell line BeWo was chosen as an experimental model for in vitro testing of a drug...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911981/ https://www.ncbi.nlm.nih.gov/pubmed/35268705 http://dx.doi.org/10.3390/molecules27051603 |
_version_ | 1784666984822079488 |
---|---|
author | Hu, Yajun Yao, Jun Wang, Zening Liang, Hui Li, Cunyu Zhou, Xinwen Yang, Fengying Zhang, Yang Jin, Hong |
author_facet | Hu, Yajun Yao, Jun Wang, Zening Liang, Hui Li, Cunyu Zhou, Xinwen Yang, Fengying Zhang, Yang Jin, Hong |
author_sort | Hu, Yajun |
collection | PubMed |
description | Trichosanthin (TCS) is a traditional Chinese herbal medicine used to treat some gynecological diseases. Its effective component has diverse biological functions, including antineoplastic activity. The human trophoblast cell line BeWo was chosen as an experimental model for in vitro testing of a drug screen for anticancer properties of TCS. The MTT method was used in this study to get a primary screen result. The result showed that 100 mM had the best IC(50) value. Proteomics analysis was then performed for further investigation of the drug effect of TCS on the BeWo cell line. In this differential proteomic expression analysis, the total proteins extracted from the BeWo cell line and their protein expression level after the drug treatment were compared by 2DE. Then, 24 unique three-fold differentially expressed proteins (DEPs) were successfully identified by MALDI-TOF/TOF MS. Label-free proteomics was run as a complemental method for the same experimental procedure. There are two proteins that were identified in both the 2DE and label-free methods. Among those identified proteins, bioinformatics analysis showed the importance of pathway and signal transduction and gives us the potential possibility for the disease treatment hypothesis. |
format | Online Article Text |
id | pubmed-8911981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89119812022-03-11 Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line Hu, Yajun Yao, Jun Wang, Zening Liang, Hui Li, Cunyu Zhou, Xinwen Yang, Fengying Zhang, Yang Jin, Hong Molecules Article Trichosanthin (TCS) is a traditional Chinese herbal medicine used to treat some gynecological diseases. Its effective component has diverse biological functions, including antineoplastic activity. The human trophoblast cell line BeWo was chosen as an experimental model for in vitro testing of a drug screen for anticancer properties of TCS. The MTT method was used in this study to get a primary screen result. The result showed that 100 mM had the best IC(50) value. Proteomics analysis was then performed for further investigation of the drug effect of TCS on the BeWo cell line. In this differential proteomic expression analysis, the total proteins extracted from the BeWo cell line and their protein expression level after the drug treatment were compared by 2DE. Then, 24 unique three-fold differentially expressed proteins (DEPs) were successfully identified by MALDI-TOF/TOF MS. Label-free proteomics was run as a complemental method for the same experimental procedure. There are two proteins that were identified in both the 2DE and label-free methods. Among those identified proteins, bioinformatics analysis showed the importance of pathway and signal transduction and gives us the potential possibility for the disease treatment hypothesis. MDPI 2022-02-28 /pmc/articles/PMC8911981/ /pubmed/35268705 http://dx.doi.org/10.3390/molecules27051603 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hu, Yajun Yao, Jun Wang, Zening Liang, Hui Li, Cunyu Zhou, Xinwen Yang, Fengying Zhang, Yang Jin, Hong Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title | Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title_full | Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title_fullStr | Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title_full_unstemmed | Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title_short | Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line |
title_sort | comparative proteomic analysis of drug trichosanthin addition to bewo cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911981/ https://www.ncbi.nlm.nih.gov/pubmed/35268705 http://dx.doi.org/10.3390/molecules27051603 |
work_keys_str_mv | AT huyajun comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT yaojun comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT wangzening comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT lianghui comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT licunyu comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT zhouxinwen comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT yangfengying comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT zhangyang comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline AT jinhong comparativeproteomicanalysisofdrugtrichosanthinadditiontobewocellline |